Privium Fund Management B.V. Ionis Pharmaceuticals Inc Transaction History
Privium Fund Management B.V.
- $354 Million
- Q2 2024
A detailed history of Privium Fund Management B.V. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Privium Fund Management B.V. holds 247,267 shares of IONS stock, worth $10.2 Million. This represents 3.33% of its overall portfolio holdings.
Number of Shares
247,267
Previous 226,993
8.93%
Holding current value
$10.2 Million
Previous $9.84 Million
19.76%
% of portfolio
3.33%
Previous 2.91%
Shares
9 transactions
Others Institutions Holding IONS
# of Institutions
394Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$569 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$519 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$424 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$340 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$270 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.83B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...